Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001313516-17-000001)

Filing Details

Accession Number:: 0001313516-17-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-16 14:14:06
Reporting Period:: 2017-06-14

Filing Date:: 2017-06-16
Accepted Time:: 2017-06-16 14:14:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1497504	Plx Pharma Inc.	PLXP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1313516	Emerson David Jorden	2635 Technology Forest Blvd. The Woodlands TX 77381	Acting Chief Financial Officer	No	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-14	32,727	$6.88	151,913	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2017-06-14	32,727	$0.00	32,727	$7.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
32,727	2017-12-15	2027-06-14	No	4	P	Direct

Footnotes

Issued pursuant to a private placement in connection with the purchase of common stock in a registered direct offering.